| Fecha | Trimestre | Sesión | BPA (est → real) | Ingresos (est → reales) |
|---|---|---|---|---|
| 4 nov 2026Próximo | Q3 2026 | Tras el cierre | 1,81 | 4,18 B |
1 sept 2026
AF Legal Group Ltd (ASX:AFL) reports a 29% surge in revenue to $35.5 million, with strong early FY27 momentum and a focus on cash generation.
28 ago 2026
Originally published on Aflac NewsroomBy Tera Ladner, senior vice president and global chief information security officer, AflacNORTHAMPTON, MA / ACCESS Newswire / August 28, 2026 / Cybersecurity is often discussed as a problem to solve - a skills gap to close, a threat to mitigate, a workforce shortage to manage. From where I sit as a top information security officer at Aflac, a leader in supplemental insurance in the U.
26 ago 2026
Aflac stock has delivered strong long term gains over the past five years, yet the current valuation signals are split between what the market is paying and what an intrinsic value estimate suggests the shares may be worth. The Excess Returns model points to a discount to intrinsic value, while earnings based multiples indicate the stock is priced more richly. A roughly 129.5% total return over five years highlights how Aflac has already rewarded patient shareholders, which raises the bar...
20 ago 2026
19 ago 2026
Wolfe Research analyst Tracy Benguigui initiates coverage on Aflac (NYSE:AFL) with a Underperform rating and announces Price Target of $103.
Wells Fargo analyst Wesley Carmichael maintains Aflac (NYSE:AFL) with a Equal-Weight and raises the price target from $120 to $122.
Aflac Incorporated (NYSE:AFL) has built an impressive dividend track record over the years. It has raised its dividend for 43 straight years, leaving the company just seven increases away from becoming a Dividend King, a milestone that requires 50 consecutive years of dividend growth. The company raised its quarterly dividend by 5.2% in early 2026 to […]
15 ago 2026
Aflac’s second quarter results were met with a negative market reaction, as sales declined year-over-year despite meeting Wall Street’s expectations. Management attributed the drop in revenue largely to tough comparisons in Japan following last year’s launch of the Miraito cancer insurance product, as well as shifting consumer preferences. CEO Daniel Amos emphasized that, while sales in Japan were down this quarter, new offerings like Tsumitasu and Anshin Palette produced solid growth. In the U.
14 ago 2026
AFL's growth in Japan and the U.S., disciplined expenses and strong premium persistency support the case for retaining the stock.
Japan sales fell 5.6% as pretax margins expanded 230 basis points.
12 ago 2026
Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.
11 ago 2026
Accident and Health Insurance stocks like AFL, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Supplemental insurance provider Aflac (NYSE:AFL) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 6.9% year on year to $4.22 billion. Its non-GAAP profit of $1.75 per share was in line with analysts’ consensus estimates.
As an extension of Aflac's long-term commitment to children and families facing cancer and blood disorders, the company today announced a new initiative to help U.S. educators teach students kindness and empathy through one of the most powerful tools available: reading. According to the International Journal on Studies in English Language and Literature (IJSELL), kindness can be explicitly and implicitly developed through sharing and discussing stories presented in children's literature.1
JP Morgan analyst Pablo Singzon maintains Aflac (NYSE:AFL) with a Neutral and lowers the price target from $117 to $116.
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Aflac (NYSE:AFL) with a Market Perform and raises the price target from $120 to $125.
10 ago 2026
As Aflac Incorporated has lagged behind the SPX over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
Piper Sandler analyst Paul Newsome maintains Aflac (NYSE:AFL) with a Overweight and raises the price target from $130 to $138.
Aflac stock has delivered a strong 142.8% return over the past five years, yet current valuation checks send mixed signals, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples lean the other way. A 142.8% gain over five years puts Aflac among the stronger long term performers, which raises the bar for any further upside from today's price. The share price can be supported if the company continues to convert earnings into steady cash flows...
9 ago 2026
7 ago 2026
Aflac (NYSE:AFL) reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted earnings of $1.75 per diluted share, as the insurer cited continued sales momentum in Japan and growth in its U.S. group insurance operations. Chief Financial Officer Max Brodén said adjusted earnings
Aflac Inc (AFL) reports adjusted EPS of $1.75, with Japan pretax margins up 230 basis points and a raised internal reinsurance target to 30% of FSA reserves.
Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.
